[{"Assets_0_Q1_USD":6862914000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":42943000.0,"NetIncomeLossConverted_1_Q1_USD":865195000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":30104000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29801000.0,"StockholdersEquity_0_Q1_USD":4863855000.0,"EarningsPerShareBasic_1_Q1_USD":29.03,"EarningsPerShareDiluted_1_Q1_USD":28.74,"RevenuesConverted_1_Q1_USD":553979000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20190510"}]